🟢 Pacific Biosciences is trading 7.65% up; no September 30 catalyst identified

Pacific Biosciences is trading up 7.65% at $1.97 on September 30, 2026; no new company announcement or clear catalyst specific to the session was identified.

• Sampled announced a five-year VA contract on September 28 worth up to $27.1 million for genomics work using PacBio Revio systems. Coverage linked the news to gains on September 28–29, not specifically to this session.
• The supplied major indices showed modest mixed moves, so a broader-market explanation is not established.